Filing Flows › Bio-Techne (TECH) › Q4 FY25
Bio-Techne (TECH) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Aug 22, 2025
Bio-Techne (TECH) reported revenue of $317M for the fourth quarter fiscal 2025 (Q4 FY25), +4% from a year earlier and +0.2% from the quarter before. Operating margin was -7.5%, net loss $17.7M (5.6% of revenue).
Bio-Techne, Q4 FY25: revenue $317M (+4% year over year), operating margin -7.5%, net loss $17.7M, operating cash flow $98.2M. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $317M | +0.2% | +4% |
| Operating profit | −$23.9M | -162% | — |
| Net earnings | −$17.7M | -178% | — |
| Operating cash flow | $98.2M | +139% | +30% |
| Free cash flow | $93.3M | +201% | +62% |
What changed
Revenue was $317.0M in Q4 FY25, up 4% year over year and roughly flat from the previous quarter. Consumables was the largest line at 80% of revenue.
Gross margin was 62.7%, down 3.7 points from a year earlier. Operating costs exceeded revenue by $23.9M, an operating margin of -7.5%. Operating expenses grew 41% against revenue growth of 4%. The fastest-growing cost line was SG&A (+47%). The quarter ended with a net loss of $17.7M, after a profit of $22.6M the previous quarter.
Operating cash flow was $98.2M (up 30% year over year). Non-cash charges added back $27.1M of depreciation and amortization and $4.5M of share-based compensation. Working capital and other items added $84.2M. Capital expenditures of $4.9M left free cash flow of $93.3M.
Questions
What was Bio-Techne's revenue in the fourth quarter fiscal 2025?
Bio-Techne (TECH) reported revenue of $317M for the fourth quarter fiscal 2025 (Q4 FY25), +4% from a year earlier and +0.2% from the quarter before.
Was Bio-Techne profitable in the fourth quarter fiscal 2025?
Operating loss was $23.9M (-7.5% of revenue) and net loss $17.7M.
Source: Bio-Techne 10-K on SEC EDGAR.